Jim Fink Investing

Publications

7/7/11 Trade Alert: A Really Cheap Drug Stock–UPDATE

Jim Fink / Options Trades

(updated with trade rationale) Sell Put Credit Spread on Amgen (Nasdaq: AMGN) “Buy to Open” August $52.50 Put and “Sell to Open” August $57.50 Put Option Symbols: AMGN110820P52.5 and AMGN110820P57.5 Limit Order Price: Net credit of $1.25 or more ($125 per spread) Directional View for Underlying Stock: Neutral to slightly bullish Options for Income Portfolio: […]… Read More


7/05/11 Weekly Briefing: Diagonal Spreads

Jim Fink / Market Briefings

Jim thinks that last week’s stock market rally is a sign of better things to come. He also explains why diagonal spreads offer both higher returns–and higher risks–than our bread-and-butter vertical spreads.

Read More


6/30/11 Trade Alert: Consumer Products Giant is Raising Prices–UPDATE

Jim Fink / Options Trades

(updated with trade rationale) Sell Put Credit Spread on Procter & Gamble (NYSE: PG) “Buy to Open” August $57.50 Put and “Sell to Open” August $62.50 Put Option Symbols: PG110820P57.5 and PG110820P62.5 Limit Order Price: Net credit of $1.25 or more ($125 per spread) Directional View for Underlying Stock: Neutral to slightly bullish Options for […]… Read More


6/27/11 Weekly Briefing: Benefiting from Time Decay a Second Way

Jim Fink / Market Briefings

Jim uses the dark art of technical analysis to downplay the chances of a severe stock market decline and delves deep into the time-value decay benefits of horizontal spreads…. Read More


6/23/11 Trade Alert: Playing a Small Business Recovery–UPDATE

Jim Fink / Options Trades

(updated with trade rationale) Sell Put Credit Spread on Intuit (NasdaqGS: INTU) “Buy to Open” October $38 Put and “Sell to Open” October $48 Put Option Symbols: INTU111022P38 and INTU111022P48 Limit Order Price: Net credit of $1.70 or more ($170 per spread) Directional View for Underlying Stock: Neutral to slightly bullish Options for Income Portfolio: […]… Read More


6/21/11 Weekly Briefing: The Virtues of Diversification

Jim Fink / Market Briefings

The recent market correction won’t morph into a more serious downturn. Nevertheless, a diversified portfolio of options can protect you from any outcome in the markets…. Read More


6/16/11 Trade Alert: High-Growth Cancer Drug Stock–UPDATE

Jim Fink / Options Trades

(updated with trade rationale) Sell Put Credit Spread on Celgene (NasdaqGS: CELG) “Buy to Open” October $45 Put and “Sell to Open” October $55 Put Option Symbols: CELG111022P45 and CELG111022P55 Limit Order Price: Net credit of $1.80 or more ($180 per spread) Directional View for Underlying Stock: Neutral to slightly bullish Options for Income Portfolio: […]… Read More


6/13/11: Weekly Briefing: Trading Options from a Stock Perspective

Jim Fink / Market Briefings

Understanding underlying company fundamentals is as important with option investing as it is with straight equities. Here, too, short-term market fluctuations often provide opportunities to establish value-based positions in good businesses…. Read More


6/9/11 Trade Alert: Bullish on Two Megatrends–UPDATE

Jim Fink / Market Briefings

(Updated with trade rationales) Trade Recommendation No. 1:   “Buy to Open” January 2013 $12.50 Call on Cisco Systems (NasdaqGS: CSCO) Option ticker symbol: CSCO130119C12.5 Limit order price: $3.80 or less ($380 per contract) Directional View for Underlying Stock: Bullish Options for Income Portfolio: Growth Current Cisco Stock Price: $15.30 Time Value Premium to Current […]… Read More


6/9/11 Trade Alert: Bullish on Two Megatrends–UPDATE

Jim Fink / Options Trades

The first tech stock is added to the Options for Income Growth Portfolio and a conservative income bet on health care rounds out this double-recommendation week.
Read More


1 411 412 413 414 415 422

Search Jim Fink Investing